These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 18252893)

  • 41. Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes.
    Berti L; Irmler M; Zdichavsky M; Meile T; Böhm A; Stefan N; Fritsche A; Beckers J; Königsrainer A; Häring HU; de Angelis MH; Staiger H
    Mol Metab; 2015 Jul; 4(7):519-27. PubMed ID: 26137439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
    Woo YC; Xu A; Wang Y; Lam KS
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):489-96. PubMed ID: 23134073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients.
    Zhang X; Hu Y; Zeng H; Li L; Zhao J; Zhao J; Liu F; Bao Y; Jia W
    Cardiovasc Diabetol; 2015 Mar; 14():32. PubMed ID: 25850006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibroblast growth factor 21, adiposity, and macronutrient balance in a healthy, pregnant population with overweight and obesity.
    Sutton EF; Morrison CD; Stephens JM; Redman LM
    Endocr Res; 2018 Nov; 43(4):275-283. PubMed ID: 29768065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma FGF21 concentrations, adipose fibroblast growth factor receptor-1 and β-klotho expression decrease with fasting in northern elephant seals.
    Suzuki M; Lee AY; Vázquez-Medina JP; Viscarra JA; Crocker DE; Ortiz RM
    Gen Comp Endocrinol; 2015 May; 216():86-9. PubMed ID: 25857751
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Attenuated fibroblast growth factor 21 response to acute aerobic exercise in obese individuals.
    Slusher AL; Whitehurst M; Zoeller RF; Mock JT; Maharaj M; Huang CJ
    Nutr Metab Cardiovasc Dis; 2015 Sep; 25(9):839-845. PubMed ID: 26141939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice.
    Chartoumpekis DV; Ziros PG; Psyrogiannis AI; Papavassiliou AG; Kyriazopoulou VE; Sykiotis GP; Habeos IG
    Diabetes; 2011 Oct; 60(10):2465-73. PubMed ID: 21852674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic Regulation of Processes Related to High Level of Fibroblast Growth Factor 21 in Obese Subjects.
    Płatek T; Polus A; Góralska J; Raźny U; Dziewońska A; Micek A; Dembińska-Kieć A; Solnica B; Malczewska-Malec M
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33670024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The single nucleotide polymorphism rs499765 is associated with fibroblast growth factor 21 and nonalcoholic fatty liver disease in a Chinese population with normal glucose tolerance.
    Jiang S; Zhang R; Li H; Fang Q; Jiang F; Hou X; Hu C; Jia W
    J Nutrigenet Nutrigenomics; 2014; 7(3):121-9. PubMed ID: 25359230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of serum bone morphogenetic protein 4 levels with obesity and metabolic syndrome in non-diabetic individuals.
    Son JW; Kim MK; Park YM; Baek KH; Yoo SJ; Song KH; Son HS; Yoon KH; Lee WC; Cha BY; Son HY; Kwon HS
    Endocr J; 2011; 58(1):39-46. PubMed ID: 21186333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of plasminogen activator inhibitor-1 and fibroblastic growth factor 21 in 3 groups of type 2 diabetes: Without overweight/obesity, free of insulin resistance, and without hepatosteatosis.
    Takebe N; Hasegawa Y; Matsushita Y; Chiba H; Onodera K; Kinno H; Oda T; Nagasawa K; Segawa T; Takahashi Y; Okada K; Ishigaki Y
    Medicine (Baltimore); 2023 Sep; 102(35):e34797. PubMed ID: 37657012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes.
    Laeger T; Baumeier C; Wilhelmi I; Würfel J; Kamitz A; Schürmann A
    Diabetologia; 2017 Nov; 60(11):2274-2284. PubMed ID: 28770320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FGF21 deficiency is associated with childhood obesity, insulin resistance and hypoadiponectinaemia: The BCAMS Study.
    Li G; Yin J; Fu J; Li L; Grant SFA; Li C; Li M; Mi J; Li M; Gao S
    Diabetes Metab; 2017 Jun; 43(3):253-260. PubMed ID: 28139438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.
    Barb D; Bril F; Kalavalapalli S; Cusi K
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3327-3336. PubMed ID: 30848827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese
    Makarova E; Kazantseva A; Dubinina A; Denisova E; Jakovleva T; Balybina N; Bgatova N; Baranov K; Bazhan N
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome.
    Ďurovcová V; Marek J; Hána V; Matoulek M; Zikán V; Haluzíková D; Kaválková P; Lacinová Z; Krsek M; Haluzík M
    Physiol Res; 2010; 59(3):415-422. PubMed ID: 19681655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction in serum fibroblast growth factor-21 after gastric bypass is related to changes in hepatic fat content.
    Fjeldborg K; Pedersen SB; Møller HJ; Richelsen B
    Surg Obes Relat Dis; 2017 Sep; 13(9):1515-1523. PubMed ID: 28552744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques.
    An SY; Lee MS; Yi SA; Ha ES; Han SJ; Kim HJ; Kim DJ; Lee KW
    Diabetes Res Clin Pract; 2012 May; 96(2):196-203. PubMed ID: 22293928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat.
    Li H; Wu G; Fang Q; Zhang M; Hui X; Sheng B; Wu L; Bao Y; Li P; Xu A; Jia W
    Nat Commun; 2018 Jan; 9(1):272. PubMed ID: 29348470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
    Li X; Wu X; Jia Y; Fu J; Zhang L; Jiang T; Liu J; Wang G
    J Diabetes Res; 2021; 2021():3715026. PubMed ID: 34660809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.